S gun/TN14003838 ; though the ncrm has a quote for 15% discount, our lab has been offered a greater discount through a bulk order. Stemcell technologies is the sole source of this product, which has…
Ended Awarded Last action
- Contract number
- HHSN26800002
- Awardee
-
Stemcell Technologies Inc. UEI ELPMWCGFK518
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,577
Award facts
- Contract value 50% obligated
-
- $9,577.00 Current, with exercised options
- $19,154.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$155 | |
| Funding Only Action | $155 | |
| Original award | $9,577 |
About this award
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company, to provide specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research initiatives across various government agencies.
The contract, valued at $19,154.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. It was awarded on December 16, 2013, with a period of performance ending on May 31, 2014. The contract is not set aside for small businesses. Stemcell Technologies Inc. is the sole source provider for the products being procured, which have been extensively used and validated in the field of stem cell biology. This award is part of a larger, single-award BPA between Stemcell Technologies Inc. and the NIH Office of Logistics and Acquisition Operations, with a ceiling value of $10,000,000 and a period of performance through December 31, 2024. The BPA facilitates the streamlined procurement of critical biomedical research supplies across various NIH institutes and centers.
Description
S gun/TN14003838 ; though the ncrm has a quote for 15% discount, our lab has been offered a greater discount through a bulk order. Stemcell technologies is the sole source of this product, which has been used in the field of stem cell biology for over five years with 500+ publications validating its effectiveness.
Quick answers
Who was awarded contract HHSN26800002?
HHSN26800002 was awarded to Stemcell Technologies Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 16, 2013.
How much is contract HHSN26800002 worth?
The government has obligated $9,577 on HHSN26800002. Its potential value, with all options, is $19,154.
Is contract HHSN26800002 an order under another contract?
Yes. HHSN26800002 is a BPA call under HHSN263200400060978B, a blanket purchase agreement.
Was contract HHSN26800002 competed?
The extent of competition for HHSN26800002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award